However, the expression of TRIM28 was positively associated only with tumor purity (p < 0.001) in PRAD (Figure 5A) and was also related to tumor immune infiltration in PRAD, ESCA, and PAAD (Figure 5B). Here, TRIM28 is linked to prostate adenocarcinoma.